第一工業製薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 化学 | 4461/E00885 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2025/05/30 | 日証協 | 450,927株 | +2.72% | 66,340株 | +368.01% | 304,102株 | -0.8% | 66,329株 | -54.65% |
2025/05/23 | 日証協 | 438,980株 | -6.34% | 14,175株 | -86.98% | 306,548株 | -6.7% | 146,263株 | +9.23% |
2025/05/16 | 日証協 | 468,674株 | +10.39% | 108,854株 | -46.17% | 328,566株 | +5.3% | 133,903株 | +39.68% |
2025/05/09 | 日証協 | 424,548株 | -0.2% | 202,235株 | +986.18% | 312,029株 | +0.9% | 95,864株 | +59.3% |
2025/05/02 | 日証協 | 425,381株 | -2.6% | 18,619株 | -66.71% | 309,241株 | -1.5% | 60,178株 | -10.22% |
2025/04/25 | 日証協 | 436,714株 | +6.36% | 55,927株 | +85.66% | 313,958株 | -10.76% | 67,027株 | -2.8% |
2025/04/18 | 日証協 | 410,593株 | +1.07% | 30,123株 | -85.46% | 351,821株 | +0.2% | 68,957株 | -50.73% |
2025/04/11 | 日証協 | 406,246株 | +2.59% | 207,227株 | +243.63% | 351,124株 | +3.91% | 139,955株 | -43.28% |
2025/04/04 | 日証協 | 395,983株 | -0.7% | 60,306株 | -9.14% | 337,897株 | -14.12% | 246,748株 | -29.51% |
2025/03/28 | 日証協 | 398,783株 | +8.13% | 66,371株 | +697.73% | 393,463株 | +27.57% | 350,048株 | +36.2% |
2025/03/21 | 日証協 | 368,804株 | +0.29% | 8,320株 | -93.91% | 308,419株 | -1.39% | 257,007株 | -14.97% |
2025/03/14 | 日証協 | 367,748株 | +48.96% | 136,517株 | -30.27% | 312,759株 | +12.49% | 302,242株 | +68.33% |
2025/03/07 | 日証協 | 246,875株 | -10.19% | 195,789株 | +390.65% | 278,026株 | +0.7% | 179,556株 | -45.4% |
2025/02/28 | 日証協 | 274,892株 | -5.74% | 39,904株 | +79.6% | 276,097株 | +4.63% | 328,858株 | +1.25% |
2025/02/21 | 日証協 | 291,625株 | -11.84% | 22,218株 | -47.05% | 263,878株 | -7.76% | 324,798株 | +7.2% |
2025/02/14 | 日証協 | 330,772株 | +10.34% | 41,961株 | -83.97% | 286,063株 | +1% | 302,995株 | -15.82% |
2025/02/07 | 日証協 | 299,772株 | +13.95% | 261,809株 | +1170.86% | 283,223株 | +10.48% | 359,928株 | -8.04% |
2025/01/31 | 日証協 | 263,062株 | -19.69% | 20,601株 | +32.9% | 256,364株 | -13.85% | 391,390株 | +114.99% |
2025/01/24 | 日証協 | 327,562株 | -2.69% | 15,501株 | +7.65% | 297,571株 | -2.07% | 182,052株 | +2.27% |
※株式分割は考慮していませんのでご注意ください。
Page Top